Related Experiment Video
Updated: Sep 16, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
SIRT1-mediated deacetylation and activation of MEK/ERK pathway decreased IL-6 in spinal dorsal horn to promote
Shenghui Hu1, Fengjia Zhou1, Baoguang Lin1
1Department of Radiotherapy, General Hospital of Northern Theater Command, Shenyang, China.
Abstract:
Oxycodone, an opioid analgesic, exhibits limited clinical utility due to the development of tolerance. This study aims to investigate the role of Sirtuin 1 (SIRT1), a histone deacetylase, in oxycodone-induced analgesic tolerance. Adult ICR mice were administered oxycodone subcutaneously once a day for seven consecutive days. The tail-flick test was used to establish a mouse model of oxycodone tolerance. RT-qPCR was employed to assess the mRNA levels of SIRT1-SIRT7. Western blotting was performed to measure the expression levels of SIRT1, interleukin (IL)-6, H3K9ac, H3K14ac, H3K18ac, total/phosphorylated extracellular signal-regulated kinase (ERK) (1/2), and mitogen-activated protein kinase/ERK kinase (MEK) (1/2). ChIP-qPCR were used to localize SIRT1/IL-6 expression, and to quantify histone acetylation at the IL-6 promoter. Mice developed analgesic tolerance by Day 7 of oxycodone administration. Oxycodone significantly reduced SIRT1 mRNA and protein levels in the lumbar spinal cord. Bioinformatics analysis identified IL-6 as the most prominently upregulated gene in the spinal cord. Correspondingly, IL-6 protein levels were elevated, along with increased levels of total H3K9ac (but not H3K14ac or H3K18ac) and enriched H3K9ac at the IL-6 promoter. While total ERK(1/2) and MEK(1/2) levels remained unchanged, their phosphorylated forms were significantly upregulated in tolerant mice. An SIRT1 agonist (SRT1720) inhibited the development of oxycodone tolerance, suppressed IL-6 overexpression, normalized H3K9ac and phospho-ERK/MEK levels, and reduced H3K9ac expression at the IL-6 promoter. Thus, SIRT1 promotes oxycodone tolerance by deacetylating histone H3K9 at the IL-6 promoter and activating the MEK/ERK pathway to upregulate IL-6 expression.
Insights
Sirtuin 1 (SIRT1) plays a key role in opioid tolerance. Reduced SIRT1 levels promote oxycodone tolerance by increasing IL-6 expression via histone modification and MEK/ERK pathway activation.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Opioid analgesics like oxycodone are limited by tolerance development.
- Sirtuin 1 (SIRT1), a histone deacetylase, is investigated for its role in this process.
Purpose of the Study:
- To elucidate the role of SIRT1 in oxycodone-induced analgesic tolerance.
- To identify molecular mechanisms underlying tolerance development.
Main Methods:
- Established oxycodone tolerance in adult ICR mice using the tail-flick test.
- Utilized RT-qPCR, Western blotting, and ChIP-qPCR to analyze gene and protein expression.
- Assessed levels of SIRT1, IL-6, histone acetylation, and MEK/ERK pathway components.
Main Results:
- Oxycodone administration led to analgesic tolerance and reduced SIRT1 levels in the spinal cord.
- Elevated IL-6 expression, increased H3K9ac at the IL-6 promoter, and activated MEK/ERK signaling were observed.
- An SIRT1 agonist (SRT1720) reversed tolerance, suppressed IL-6, and normalized molecular markers.
Conclusions:
- SIRT1 is crucial in promoting oxycodone tolerance.
- SIRT1 facilitates tolerance by deacetylating H3K9 at the IL-6 promoter, upregulating IL-6 via the MEK/ERK pathway.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Desensitization and Tachyphylaxis
Opioid Analgesics: Morphine and Other Natural Cogeners

